Wells Fargo analyst Simran Kaur raised the firm’s price target on Staar Surgical to $30.75 from $28 and keeps an Equal Weight rating on the shares. The firm notes Alcon (ALC) announced it is increasing its bid price for Staar (STAA) from $28/share to $30.75/share, or a total equity value of $1.6B. Vote is expected next Friday.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Staar Surgical price target raised to $30.75 from $28 at Canaccord
- Broadwood continues to urge Staar shareholders to vote against Alcon transaction
- Midday Fly By: Nvidia can ship H200s to China, Campbell’s reports Q1 beat
- Alcon amends merger agreement with Staar Surgical, increases acquisition price
- Staar Surgical Amends Merger Agreement with Alcon